Early diagnosis of Alzheimer’s disease: the role of biomarkers including advanced EEG signal analysis. Report from the IFCN-sponsored panel of experts
Year: 2020
Type: review
Source: Clinical Neurophysiology
Institutions: IRCCS San Raffaele Roma, Agostino Gemelli University Polyclinic, Istituti di Ricovero e Cura a Carattere Scientifico, Sapienza University of Rome, Brighton and Sussex Medical School, University of Sussex, Fondazione Santa Lucia, Istituto Universitario di Studi Superiori di Pavia, Centro San Giovanni di Dio Fatebenefratelli, University of Edinburgh, Universidade Federal do ABC, University Hospital of Geneva, Istanbul Medipol University, University of Bari Aldo Moro, Università Cattolica del Sacro Cuore, National Research Council, Institute of Cognitive Sciences and Technologies, Beth Israel Deaconess Medical Center, Harvard University, Berenson Allen Center for Noninvasive Brain Stimulation, Centre National de la Recherche Scientifique, Inserm, Sorbonne Université, Pitié-Salpêtrière Hospital, Institut du Cerveau, Université Pierre-et-Marie-Curie
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: Alzheimer's disease, early diagnosis, biomarkers, EEG, EEG signal analysis, prodromal Alzheimer's disease, cognitive decline, neuroimaging biomarkers, cerebrospinal fluid biomarkers, genetic risk factors, neuropsychological assessment, fluid biomarkers, disease-modifying drugs, conversion to dementia
Open Access status: green
OpenAlex ID: W3011856986
